Table 2.
Medication and Treatment Data Pre and During-Pandemic
SZ | CHR | X2, p value | |
---|---|---|---|
% Taking medications for any psychiatric conditions | |||
Pre-pandemic | 93% | 52% | 13.2, p < 0.001 |
During pandemic | 90% | 60% | 6.8, p = 0.01 |
% Reporting they missed taking medications for any reason | |||
Pre-pandemic | 21% | 8% | 2.03, p = 0.27 |
During pandemic | 24% | 24% | 0.00, p = 1.0 |
% Missing scheduled appointments with healthcare providers | |||
Pre-pandemic | 17% | 8% | 1.3, p = 0.44 |
During PANDEMIC | 37% | 28% | .47, p = 0.57 |
% With access to remote healthcare (e.g., teletherapy/video therapy) | |||
Pre-pandemic | 23% | 4% | 5.65, p = 0.03 |
During pandemic | 83% | 44% | 9.3, p = 0.004 |
SZ schizophrenia, CHR clinical high-risk for psychosis